1. Signaling Pathways
  2. Immunology/Inflammation
  3. CD74


HLA-DR-gamma; Invariant polypeptide of major histocompatibility complex, class II antigen-associated


CD74 Related Products (1):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P99731
    Inhibitor 99.39%
    Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death.